KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ionis Pharmaceuticals (IONS) Times Interest Earned: 2009-2025

Historic Times Interest Earned for Ionis Pharmaceuticals (IONS) over the last 17 years, with Sep 2025 value amounting to -$38.03.

  • Ionis Pharmaceuticals' Times Interest Earned fell 6.45% to -$38.03 in Q3 2025 from the same period last year, while for Sep 2025 it was -$16.72, marking a year-over-year increase of 21.61%. This contributed to the annual value of -$27.96 for FY2024, which is 0.05% down from last year.
  • Latest data reveals that Ionis Pharmaceuticals reported Times Interest Earned of -$38.03 as of Q3 2025, which was down 211.90% from $33.99 recorded in Q2 2025.
  • Ionis Pharmaceuticals' 5-year Times Interest Earned high stood at $98.57 for Q4 2021, and its period low was -$120.17 during Q4 2022.
  • In the last 3 years, Ionis Pharmaceuticals' Times Interest Earned had a median value of -$35.73 in 2024 and averaged -$27.14.
  • Per our database at Business Quant, Ionis Pharmaceuticals' Times Interest Earned soared by 1,158.61% in 2021 and then plummeted by 1,868.73% in 2024.
  • Over the past 5 years, Ionis Pharmaceuticals' Times Interest Earned (Quarterly) stood at $98.57 in 2021, then plummeted by 221.91% to -$120.17 in 2022, then skyrocketed by 98.88% to -$1.34 in 2023, then slumped by 1,868.73% to -$26.44 in 2024, then dropped by 6.45% to -$38.03 in 2025.
  • Its last three reported values are -$38.03 in Q3 2025, $33.99 for Q2 2025, and -$35.75 during Q1 2025.